FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2004308687> ?p ?o ?g. }

• W2004308687 endingPage "e90232" @default.
• W2004308687 startingPage "e90232" @default.
• W2004308687 abstract "Rationale Infection of the lung with Pseudomonas aeruginosa results in upregulation of nitric oxide synthases (NOS) and arginase expression, and both enzymes compete for L-arginine as substrate. Nitric oxide (NO) production may be regulated by arginase as it controls L-arginine availability for NOS. We here studied the effect of systemic arginase inhibition on pulmonary L-arginine metabolism in Pseudomonas pneumonia in the mouse. Methods Mice (C57BL/6, 8–10 weeks old, female) underwent direct tracheal instillation of Pseudomonas (PAO-1)-coated agar beads and were treated by repeated intra-peritoneal injections of the arginase inhibitor 2(S)-amino-6-boronohexanoic acid (ABH) or PBS until lungs were harvested on day 3 of the infection. L-arginine metabolites were quantified using liquid chromatography-tandem mass spectrometry, NO metabolites nitrate and nitrite by Griess reagent and cytokines by ELISA. Results NO metabolite concentrations (48.5±2.9 vs. 10.9±2.3 µM, p<0.0001), as well as L-ornithine (29.6±1.7 vs 2.3±0.4 µM, p<0.0001), the product of arginase activity, were increased in Pseudomonas infected lungs compared to naïve controls. Concentrations of the NOS inhibitor asymmetric dimethylarginine (ADMA) were also increased (0.44±0.02 vs. 0.16±0.01 µM, p<0.0001). Arginase inhibition in the infected animals resulted in a significant decrease in L-ornithine (14.6±1.6 µM, p<0.0001) but increase in L-arginine concentration (p<0.001), L-arginine/ADMA ratio (p<0.001), L-arginine availability for NOS (p<0.001), and NO metabolite concentrations (67.3±5.7 µM, p<0.05). Arginase inhibitor treatment also resulted in an increase in NO metabolite levels in animals following intratracheal injection of LPS (p = 0.015). Arginase inhibition was not associated with an increase in inflammatory markers (IFN-γ, IL-1β, IL-6, MIP-2, KC or TNF-α) in lung. Concentrations of the L-ornithine-dependent polyamines putrescine, spermidine and spermine were increased in Pseudomonas infected lungs (p<0.001, respectively) but were unaffected by ABH treatment. Conclusions Systemic arginase inhibition with ABH during Pseudomonas pneumonia in mice results in an increase in pulmonary NO formation but no pro-inflammatory effect." @default.
• W2004308687 created "2016-06-24" @default.
• W2004308687 creator A5001502733 @default.
• W2004308687 creator A5017024281 @default.
• W2004308687 creator A5028582333 @default.
• W2004308687 creator A5036829849 @default.
• W2004308687 creator A5044186049 @default.
• W2004308687 creator A5047655657 @default.
• W2004308687 creator A5086957322 @default.
• W2004308687 date "2014-03-03" @default.
• W2004308687 modified "2023-10-14" @default.
• W2004308687 title "Effect of Arginase Inhibition on Pulmonary L-Arginine Metabolism in Murine Pseudomonas Pneumonia" @default.
• W2004308687 cites W1964746927 @default.
• W2004308687 cites W1970924569 @default.
• W2004308687 cites W1973018387 @default.
• W2004308687 cites W1987244469 @default.
• W2004308687 cites W1988459550 @default.
• W2004308687 cites W2003319782 @default.
• W2004308687 cites W2013023382 @default.
• W2004308687 cites W2016785586 @default.
• W2004308687 cites W2018037431 @default.
• W2004308687 cites W2021324668 @default.
• W2004308687 cites W2028910666 @default.
• W2004308687 cites W2046888743 @default.
• W2004308687 cites W2049292864 @default.
• W2004308687 cites W2054510493 @default.
• W2004308687 cites W2056666403 @default.
• W2004308687 cites W2090028381 @default.
• W2004308687 cites W2105008011 @default.
• W2004308687 cites W2107668920 @default.
• W2004308687 cites W2109306328 @default.
• W2004308687 cites W2112204405 @default.
• W2004308687 cites W2112594020 @default.
• W2004308687 cites W2113120391 @default.
• W2004308687 cites W2124431888 @default.
• W2004308687 cites W2127639563 @default.
• W2004308687 cites W2129315200 @default.
• W2004308687 cites W2130115940 @default.
• W2004308687 cites W2139426378 @default.
• W2004308687 cites W2139868508 @default.
• W2004308687 cites W2139969059 @default.
• W2004308687 cites W2147974982 @default.
• W2004308687 cites W2150010656 @default.
• W2004308687 cites W2156214513 @default.
• W2004308687 cites W2165987820 @default.
• W2004308687 cites W2168747441 @default.
• W2004308687 cites W2170595420 @default.
• W2004308687 cites W2324058848 @default.
• W2004308687 cites W2335528198 @default.
• W2004308687 doi "https://doi.org/10.1371/journal.pone.0090232" @default.
• W2004308687 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3940779" @default.
• W2004308687 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24595185" @default.
• W2004308687 hasPublicationYear "2014" @default.
• W2004308687 type Work @default.
• W2004308687 sameAs 2004308687 @default.
• W2004308687 citedByCount "19" @default.
• W2004308687 countsByYear W20043086872014 @default.
• W2004308687 countsByYear W20043086872015 @default.
• W2004308687 countsByYear W20043086872016 @default.
• W2004308687 countsByYear W20043086872018 @default.
• W2004308687 countsByYear W20043086872019 @default.
• W2004308687 countsByYear W20043086872020 @default.
• W2004308687 countsByYear W20043086872021 @default.
• W2004308687 countsByYear W20043086872022 @default.
• W2004308687 crossrefType "journal-article" @default.
• W2004308687 hasAuthorship W2004308687A5001502733 @default.
• W2004308687 hasAuthorship W2004308687A5017024281 @default.
• W2004308687 hasAuthorship W2004308687A5028582333 @default.
• W2004308687 hasAuthorship W2004308687A5036829849 @default.
• W2004308687 hasAuthorship W2004308687A5044186049 @default.
• W2004308687 hasAuthorship W2004308687A5047655657 @default.
• W2004308687 hasAuthorship W2004308687A5086957322 @default.
• W2004308687 hasBestOaLocation W20043086871 @default.
• W2004308687 hasConcept C126322002 @default.
• W2004308687 hasConcept C134018914 @default.
• W2004308687 hasConcept C164007495 @default.
• W2004308687 hasConcept C178790620 @default.
• W2004308687 hasConcept C185592680 @default.
• W2004308687 hasConcept C2776179834 @default.
• W2004308687 hasConcept C2776384668 @default.
• W2004308687 hasConcept C2776796294 @default.
• W2004308687 hasConcept C2777468819 @default.
• W2004308687 hasConcept C2777477808 @default.
• W2004308687 hasConcept C2777622882 @default.
• W2004308687 hasConcept C2777637488 @default.
• W2004308687 hasConcept C2779877776 @default.
• W2004308687 hasConcept C515207424 @default.
• W2004308687 hasConcept C519581460 @default.
• W2004308687 hasConcept C523546767 @default.
• W2004308687 hasConcept C54355233 @default.
• W2004308687 hasConcept C55493867 @default.
• W2004308687 hasConcept C71924100 @default.
• W2004308687 hasConcept C86803240 @default.
• W2004308687 hasConcept C89423630 @default.
• W2004308687 hasConcept C98274493 @default.
• W2004308687 hasConceptScore W2004308687C126322002 @default.
• W2004308687 hasConceptScore W2004308687C134018914 @default.
• W2004308687 hasConceptScore W2004308687C164007495 @default.

• next